IN RE: NAVIDEA BIOPHARMACEUTICALS LITIGATION

CourtDistrict Court, S.D. New York
DecidedMay 27, 2021
Docket1:19-cv-01578
StatusUnknown

This text of IN RE: NAVIDEA BIOPHARMACEUTICALS LITIGATION (IN RE: NAVIDEA BIOPHARMACEUTICALS LITIGATION) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
IN RE: NAVIDEA BIOPHARMACEUTICALS LITIGATION, (S.D.N.Y. 2021).

Opinion

UNITED STATES DISTRICT COURT EDLOECC #T:R ONIC ALLY FILED SOUTHERN DISTRICT OF NEW YORK DATE FILED: 5/27/2 021 -------------------------------------------------------------- X : 19-CV-1578 (VEC) IN RE: NAVIDEA BIOPHARMACEUTICALS : LITIGATION : OPINION AND ORDER : -------------------------------------------------------------- X VALERIE CAPRONI, United States District Judge: Navidea Biopharmaceuticals, Inc. (“Navidea”) sued Michael Goldberg (“Goldberg”) for breach of contract, breach of the covenant of good faith and fair dealing, breach of fiduciary duty, and for a declaratory judgment establishing the contractual rights and obligations of the parties. See Am. Compl., Dkt. 15. Goldberg asserted counterclaims against Navidea and third- party claims against Macrophage Therapeutics, Inc. (“Macrophage”), a subsidiary of Navidea. Dkt. 31. Goldberg moved to dismiss Plaintiff’s breach of fiduciary duty claim and sought attorneys’ fees in connection with defending against that claim. Dkt. 32. On December 26, 2019, the Undersigned granted Goldberg’s motion to dismiss the breach of fiduciary duty claim and determined that he was entitled to attorneys’ fees with respect to his defense of that claim. Dkt. 61. The Court directed the parties to meet and confer regarding an appropriate amount of attorneys’ fees; on February 20, 2020, Goldberg informed the Court that the parties were unable to reach an agreement on an amount. Dkt. 78. Goldberg also filed a separate motion for advancement of attorneys’ fees incurred in defending against Navidea’s remaining claims and fees incurred in defending claims brought by Macrophage against him in an entirely separate proceeding in Delaware Chancery Court. See Dkt. 64. On February 20, 2020, the Undersigned referred the motions to Magistrate Judge Freeman for a report and recommendation. Dkt. 119. On July 9, 2020, Magistrate Judge Freeman issued a Report and Recommendation (“R&R”) recommending, inter alia, that: (i) the Court find that Goldberg is entitled to indemnification for attorneys’ fees reasonably incurred in defending the breach of fiduciary duty claim; (ii) the Court find that Goldberg is entitled to advancement of attorneys’ fees reasonably

incurred to date in defending against Navidea’s remaining claims; (iii) the Court decline to award Goldberg any specific amount of fees until he makes properly supported fee applications to support his requests for indemnification and advancement; and (iv) the Court adopt a protocol by which the parties will handle the advancement of fees going forward. Dkt. 119. On August 24, 2020, this Court adopted Magistrate Judge Freeman’s R&R in its entirety. Dkt. 134. Specifically, the Court held that Goldberg is entitled to indemnification for attorneys’ fees reasonably incurred in defending against the breach of fiduciary duty claim and to advancement of attorneys’ fees reasonably incurred in defending against Navidea’s remaining claims, provided he tenders the necessary undertaking to repay the advancement if it is ultimately determined that he is not entitled to indemnification under Navidea’s bylaws. Id. at 5-

9. Nevertheless, the Court declined to award any fees because Goldberg had not made a properly supported fee application. Id. at 7-8, 11. The Court ordered Goldberg to make a properly supported fee application in support of his indemnification and advancement claims by September 30, 2020; the Court explicitly directed Goldberg to submit copies of his attorneys’ billing records that specifically detail the time each attorney spent working on each of Navidea’s claims and explaining the nature of the work performed. Id. at 7, 11, 13. The Court warned Goldberg that failure to comply with its order would likely result in the Court finding that Goldberg has “withdrawn with prejudice his request for indemnification [and advancement] as a

2 sanction for his failure to comply with this and previous court orders.” Id. at 7-8, 12 (citing Rice v. NBCUniversal Media LLC, No. 19-CV-447, 2019 WL 3000808, at *3 (S.D.N.Y. July 10, 2019) (district court may impose sanctions under Federal Rule of Civil Procedure 16(f) when there is “clear and convincing evidence that counsel disregarded a clear and unambiguous …

pretrial order.”)). The Court declined to decide whether Goldberg was entitled to advancement for fees and costs incurred in prosecuting his counterclaims against Navidea because the issue had not been properly raised before Magistrate Judge Freeman. Id. at 11 n.10. The Court explained that Goldberg could renew his request for advancement related to his counterclaims in his subsequent fee application but cautioned him that should he “choose to seek advancement of attorneys’ fees incurred in connection with his counterclaims,” he must submit billing records that “specify which time entries correspond to time spent prosecuting each counterclaim.” Id. at 11 n.10 (emphasis in original). Finally, the Court held that Goldberg was not entitled to advancement of fees and costs related to the prosecution of his third-party claims against Macrophage. Id. at 7 n.6, 11 n.10 On October 2, 20201, Goldberg filed a letter motion seeking indemnification or

advancement of attorneys’ fees, supported by, inter alia, Declarations of Gregory Zimmer, Esq. and Michael Goldberg, and exhibits thereto. Dkt. 141. On October 7, 2021, with Magistrate Judge Freeman’s permission, Goldberg supplemented the application with a Declaration of N. Ari Weistbrot, Esq. and exhibits thereto. Dkt. 142. Goldberg did not file a memorandum of law in support of his renewed application for indemnification and advancement of fees. Inexplicably, on November 13, 2020, Goldberg filed another fee application, this one seeking

1 Magistrate Judge Freeman granted Goldberg an extension from the September 30, 2020 deadline to file the fee application. Dkt. 139. 3 advancement of fees incurred in connection with the prosecution of his counterclaims against Navidea and his third-party claims against Macrophage. Dkt. 165. Navidea opposed both fee applications. Dkts. 155, 173. Then, on February 1, 2021, Goldberg filed a motion to compel Navidea to comply with the ongoing advancement protocol established by this Court in its prior

opinion, see Dkt. 134 at 12-13, and to hold Navidea in contempt for failing to comply up until that point. Dkt. 184. On April 21, 2021, Magistrate Judge Freeman issued a thorough and excellent fifty-one- page R&R recommending that Goldberg’s fee applications be granted in part and denied in part. See R&R, Dkt. 198. Specifically, Magistrate Judge Freeman recommends that: (i) the Court award Goldberg $14,955.00 as indemnification for the fees his attorneys have shown were reasonably incurred in defending against the breach of fiduciary duty claim; (ii) the Court award Goldberg $1,237.50 as advancement for the fees his attorneys have shown were reasonably incurred in defending against Navidea’s remaining claims; (iii) the Court decline to award Goldberg any attorneys’ fees related to the prosecution of his counterclaims and third-party

claims; (iv) the Court decline to award Goldberg any advancement of litigation costs incurred to date; and (v) the Court deny Goldberg’s motion to compel Navidea to comply with the advancement protocol and to hold Navidea in contempt for its prior failure to do so. Id. On May 5, 2021, Goldberg submitted objections to the R&R. Dkt. 199. For the following reasons, the Court ADOPTS the R&R in full. DISCUSSION In reviewing a report and recommendation, a district court “may accept, reject, or modify, in whole or in part, the findings or recommendations made by the magistrate judge.”

4 28 U.S.C. § 636(b)(1)(C).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Watson v. Geithner
355 F. App'x 482 (Second Circuit, 2009)
Hensley v. Eckerhart
461 U.S. 424 (Supreme Court, 1983)
Blum v. Stenson
465 U.S. 886 (Supreme Court, 1984)
Scott v. City of New York
626 F.3d 130 (Second Circuit, 2010)
Millea v. Metro-North Railroad
658 F.3d 154 (Second Circuit, 2011)
United States v. Male Juvenile (95-Cr-1074)
121 F.3d 34 (Second Circuit, 1997)
Williams v. New York City Housing Authority
975 F. Supp. 317 (S.D. New York, 1997)
Ortiz v. Barkley
558 F. Supp. 2d 444 (S.D. New York, 2008)
Sun-Times Media Group, Inc. v. Black
954 A.2d 380 (Court of Chancery of Delaware, 2008)
Wilds v. United Parcel Service, Inc.
262 F. Supp. 2d 163 (S.D. New York, 2003)
HTV Indus., Inc. v. Agarwal
317 F. Supp. 3d 707 (S.D. Illinois, 2018)
Davidson v. Keenan
740 F.2d 129 (Second Circuit, 1984)

Cite This Page — Counsel Stack

Bluebook (online)
IN RE: NAVIDEA BIOPHARMACEUTICALS LITIGATION, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-navidea-biopharmaceuticals-litigation-nysd-2021.